Kaliumjodid G.L.

Potassium iodide, the active ingredient in Kaliumjodid G.L., is a iodide presented as an unspecified strength/oral tablet for oral use. It provides thyroid blocking in case of radioactive iodine exposure and helps prevent iodine deficiency. GNH USA supplies Kaliumjodid G.L. as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumjodid G.L. is used to address conditions related to iodine metabolism and radiation exposure. - Radioactive iodine exposure: provides thyroid blocking to reduce uptake of radioactive iodine. - Iodine deficiency: supplies stable iodine to prevent deficiency in populations at risk. - Nuclear emergency preparedness: used as a prophylactic measure to protect the thyroid during radiological incidents.

Potassium iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Metallic or salty taste in the mouth. - Nausea or vomiting. - Mild abdominal discomfort or diarrhea. - Headache. - Mild skin rash.

Serious or Rare Side Effects: - Allergic reactions such as urticaria or anaphylaxis. - Iodide‑induced hyperthyroidism or hypothyroidism. - Pulmonary edema (rare). - Severe gastrointestinal irritation. - Acute kidney injury in susceptible individuals.

Before using Kaliumjodid G.L., consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Pre‑existing thyroid disease: use under medical supervision. - Renal impairment: monitor kidney function during therapy. - Concomitant medications affecting iodine metabolism: assess for interactions. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Potassium iodide can interact with several medications; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Antithyroid drugs (e.g., methimazole, propylthiouracil): may reduce effectiveness of potassium iodide. - Lithium: concurrent use can exacerbate thyroid dysfunction. - Amiodarone: may increase risk of thyroid abnormalities.

Moderate Interactions (Monitor Closely): - ACE inhibitors or potassium‑sparing diuretics: monitor serum potassium levels. - Radioactive iodine therapy: adjust timing to avoid reduced therapeutic efficacy.